Molecular Partners AG
MOLN | NASDAQ
$3.58
+$0.05 (+1.42%)
At close: Oct 30, 2026, 4:00 PM ET
$3.08
-$0.50 (-13.97%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
+1.42%
(1D)No price chart data available for 1D timeframe.
Rating
27.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #855/1028 (Top 83%)
Key Statistics
Market Data
Market Cap $137.13M
1D Range
3.51 3.58
52W Range
3.51 5.13
Valuation (TTM)
PE -2.13
PB 2.26
EV/EBITDA -1.15
Valuation (NTM)
Forward PE N/A
Forward PEG 0.17
Price Target $21.00
Cash Flow
FCF Yield -43.7%
SBC Adj. FCF Yield -46.2%
SBC Impact -5.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-94.9%
Dil EPS 3Y | 5Y 16.6% |
-138.8%
FCF 3Y | 5Y 9.0% |
-144.1%
Returns
ROA -79.2%
ROE -79.3%
ROIC -91.8%
Financial Health
Net Cash
CHF57.49M ($68.79M)
Current Ratio 6.46
Interest Coverage -1,361.24
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, specializing in the identification, advancement, and commercialization of innovative therapeutic proteins. The firm's pipe...
Sector Healthcare
Industry Biotechnology
Employees 134
IPO Date Jun 16, 2021
Website www.molecularpartners.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$21.00
Upside
+486.59%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MOLN